Clearview News Wire
Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
EU agency says Gardasil vaccine safe to use
Last Updated: 2009-02-19 15:53:37 -0400 (Reuters Health)February 20, 2009
LONDON (Reuters) - European regulators gave Merck and Co Inc's Gardasil a clean bill of health on Thursday, saying the cervical cancer vaccine was safe and did not make two Spanish girls ill.The European Medicines Agency said its committee of experts had reviewed the cases of the two girls who became ill after the shots and determined their illness was unlikely to be related to vaccination with Gardasil.
"Therefore the Committee is recommending that vaccination with Gardasil should continue in accordance with national vaccination programmes in member states," the EU agency said.
Earlier this week, the Spanish region of Valencia resumed cervical cancer vaccinations with Gardasil after its use was halted when two girls fell ill. Both had received injections from the same batch of the drug.
Merck markets the vaccine, which protects against cancer-causing strains of the sexually transmitted human papillomavirus (HPV), in Europe with Sanofi-Aventis SA .
It competes with GlaxoSmithKline Plc's Cervarix.
Tweet
Other Articles:
- May 15, 2013
- Actress has double mastectomy to elude breast cancer
- May 15, 2013
- FDA strengthens warnings on tanning beds
- April 30, 2013
- Supplements don't help with prostate cancer: study
- April 25, 2013
- New York City aims to ban cigarette sales under 21s
- April 4, 2013
- Smokers have worse colon cancer prognosis
- April 3, 2013
- Counsel women with likely BRCA family history
- March 28, 2013
- Soy tied to better lung cancer survival among women.